These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31582673)

  • 1. Evaluation of perceptions, knowledge and compliance with guidelines in real-life practice: A survey on the under-treatment of hypercholesterolemia.
    Doğan V; Başaran Ö; Özlek B; Çelik O; Özlek E; Çil C; Özdemir IH; Rencüzoğulları I; Özpamuk Karadeniz F; Bekar L; Aktas M; Resulzade MM; Kalçık M; Aksan G; Çinier G; Halli Akay K; Mert KU; Biteker M; Kayıkçıoğlu M
    Turk Kardiyol Dern Ars; 2019 Oct; 47(7):599-608. PubMed ID: 31582673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale, design, and methodology of the Evaluation of Perceptions, Knowledge, and Compliance with the Guidelines in Real Life Practice: A Survey on the Under-treatment of Hypercholesterolemia.
    Doğan V; Başaran Ö; Özlek B; Çelik O; Özlek E; Mert KU; Rencüzoğulları İ; Mert GÖ; Doğan MM; Biteker M; Kayıkçıoğlu M
    Turk Kardiyol Dern Ars; 2018 Jan; 46(1):47-53. PubMed ID: 29339691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reasons of poor lipid target attainment for secondary prevention in real life practice: Results from EPHESUS.
    Mert GÖ; Başaran Ö; Mert KU; Doğan V; Özlek B; Çelik O; Özlek E; Çil C; Özdemir İH; Rencüzoğulları İ; Karadeniz FÖ; Bekar L; Aktaş M; Resulzade MM; Kalçık M; Aksan G; Çinier G; Akay K; Pekel N; Şenol U; Biteker M; Kayıkçıoğlu M
    Int J Clin Pract; 2019 Sep; 73(9):1-9. PubMed ID: 31038781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based survey.
    Krempf M; Simpson RJ; Ramey DR; Brudi P; Giezek H; Tomassini JE; Lee R; Farnier M
    Lipids Health Dis; 2015 May; 14():45. PubMed ID: 25985907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lipid-lowering therapy and patient adherence in the MULTI GAP 2013 trial].
    Simonyi G
    Orv Hetil; 2014 Apr; 155(17):669-75. PubMed ID: 24755449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adherence to statin therapy and LDL cholesterol goal attainment in type 2 diabetics and secondary prevention patients: the role of education and knowledge].
    Yiğiner O; Ozmen N; Ozçelik F; Inanç T; Kardeşoğlu E; Uz O; Işılak Z; Aparcı M; Sahin I; Arslan E; Cebeci BS
    Turk Kardiyol Dern Ars; 2010 Dec; 38(8):544-50. PubMed ID: 21248454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The From The Heart study: a global survey of patient understanding of cholesterol management and cardiovascular risk, and physician-patient communication.
    Hobbs FD; Erhardt LR; Rycroft C;
    Curr Med Res Opin; 2008 May; 24(5):1267-78. PubMed ID: 18355420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient characteristics and statin discontinuation-related factors during treatment of hypercholesterolemia: an observational non-interventional study in patients with statin discontinuation (STAY study).
    Tokgözoğlu L; Özdemir R; Altındağ R; Ceyhan C; Yeter E; Öztürk C; Bayram F; Delibaşı T; Değertekin M; Dinçkal MH; Keleş İ; Fak AS; Aydoğdu S; Zorkun C; Tartan Z
    Turk Kardiyol Dern Ars; 2016 Jan; 44(1):53-64. PubMed ID: 26875131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk assessment of atherosclerotic cardiovascular diseases before statin therapy initiation: Knowledge, attitude, and practice of physicians in Yemen.
    Al-Ashwal FY; Sulaiman SAS; Sheikh Ghadzi SM; Kubas MA; Halboup A
    PLoS One; 2022; 17(5):e0269002. PubMed ID: 35617266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Statin Prescribing for Secondary Prevention in Primary Care Following New Guideline Recommendations.
    Zupec JF; Marrs JC; Saseen JJ
    Ann Pharmacother; 2016 Jan; 50(1):17-21. PubMed ID: 26416950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gap between the current dyslipidemia guidelines and the physicians' treatment targets in patients with type 2 diabetes in Turkey.
    Kahya Eren N; Harman E; Dolek D; Emren S; Tütüncüoğlu AP; Nazli C; Ergene O
    Minerva Cardioangiol; 2014 Jun; 62(3):287-95. PubMed ID: 24831765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol complacency in Australia: time to revisit the basics of cardiovascular disease prevention.
    Carrington MJ; Retegan C; Johnston CI; Jennings GL; Stewart S
    J Clin Nurs; 2009 Mar; 18(5):678-86. PubMed ID: 19077020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
    Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Management of Statin-Associated Symptoms in Clinical Practice: Extension of a Clinician Survey to 12 Further Countries.
    Rosenson RS; Gandra SR; McKendrick J; Dent R; Wieffer H; Cheng LI; Catapano AL; Oh P; Kees Hovingh G; Stroes ES
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):187-195. PubMed ID: 28466399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice.
    Arca M; Ansell D; Averna M; Fanelli F; Gorcyca K; Iorga ŞR; Maggioni AP; Paizis G; Tomic R; Catapano AL
    Atherosclerosis; 2018 Apr; 271():120-127. PubMed ID: 29499359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The new lipid guidelines: what do primary care clinicians think?
    Jamé S; Wittenberg E; Potter MB; Fleischmann KE
    Am J Med; 2015 Aug; 128(8):914.e5-914.e10. PubMed ID: 25837518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients.
    Okerson T; Patel J; DiMario S; Burton T; Seare J; Harrison DJ
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28314797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cultural Barriers in the Treatment of Dyslipidemia: A Survey of Japanese Physician Attitudes.
    Yamashita S; Masuda D; Arai H; Matsuzawa Y
    J Atheroscler Thromb; 2019 Feb; 26(2):154-169. PubMed ID: 29780067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of physician attitudes and beliefs on treatment decisions: lipid therapy in high-risk patients.
    Foley KA; Denke MA; Kamal-Bahl S; Simpson R; Berra K; Sajjan S; Alexander CM
    Med Care; 2006 May; 44(5):421-8. PubMed ID: 16641660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.